Form 4 for IMAX IMAX CORP
Accepted 2025-11-07 00:00:00 ET · period of report 2025-11-07 · accession 0001214659-25-016100 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-07 | 2025-11-07 | IMAX | LISTER ROBERT D | CLO Sr EVP | C - Cnv Deriv | $22.49 | +50.1K | 211.6K | +31% | +$1.13M |
| D | 2025-11-07 | 2025-11-07 | IMAX | LISTER ROBERT D | CLO Sr EVP | S - Sale | $34.67 | -50.1K | 161.4K | -24% | -$1.74M |
| D | 2025-11-07 | 2025-11-07 | IMAX | LISTER ROBERT D | CLO Sr EVP | C - Cnv Deriv | $22.49 | -50.1K | 0 | -100% | -$1.13M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common shares | 2025-11-07 | C | A | 50,143 | $22.49 | 211,564 | D | — | — | (F1) Represents the conversion upon exercise of stock options into common shares, pursuant to a 10b5-1 Plan dated June 11, 2025. |
| 2 | Common | common shares | 2025-11-07 | S | D | 50,143 | $34.67 | 161,421 | D | — | — | |
| 3 | Derivative | stock options (to buy) | 2025-11-07 | C | D | 50,143 | $22.49 | 0 | D | $22.49 · — to 2026-03-07 | 50,143 common shares | (F2) These options were issued in 2019 and are set to expire on March 7, 2026. (F4) Mr. Lister's aggregate remaining restricted share unit and common share balances following these transactions will be 70,609 and 161,421, respectively. (F3) The stock options became exercisable in four installments: 12,535 on each of March 7, 2020, March 7, 2021 and March 7, 2022 and 12,538 on March 7, 2023. |